Cue Biopharma, Inc. (CUE) vs Quanterix Corporation (QTRX)
A side-by-side comparison of Cue Biopharma, Inc. and Quanterix Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CUE
Cue Biopharma, Inc.
$23.14HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
QTRX
Quanterix Corporation
$3.44HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — CUE vs QTRX
growth of $100 · dividends reinvested · last 9yCUE -93.0% (-25.6%/yr)QTRX -82.3% (-17.5%/yr)QTRX compounded faster over this window
CUE QTRX
CUE vs QTRX: by the numbers
- •CUE is the larger company ($168M vs $162M market cap).
- •Both run net losses; QTRX's is the smaller (-80.29% vs -435.83% net margin).
- •CUE grew revenue faster over the past five years (47.08% vs 7.23% CAGR).
Metrics side by side
Valuation
| Metric | CUE | QTRX |
|---|---|---|
| P/S ratio | 4.46 | 1.06 |
| P/B ratio | 72.77 | 0.68 |
Profitability
| Metric | CUE | QTRX |
|---|---|---|
| Gross margin | 99.69% | 42.60% |
| Operating margin | -96.56% | -86.19% |
| Net margin | -435.83% | -80.29% |
| ROE | -7104.24% | -51.90% |
| ROIC | -1039.56% | -49.08% |
Growth (annualized)
| Metric | CUE | QTRX |
|---|---|---|
| Revenue CAGR (5Y) | 47.08% | 7.23% |
| Total return CAGR (5Y) | -42.42% | -39.63% |
Frequently asked
- Which has grown faster, CUE or QTRX?
- Over the past five years, CUE grew revenue faster — CUE at a 47.08% CAGR versus QTRX at 7.23%.
- How have CUE and QTRX total returns compared?
- Over the past 5 years, CUE delivered -42.42% and QTRX delivered -39.63% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Cue Biopharma ROEQuanterix ROECue Biopharma operating marginQuanterix operating marginCue Biopharma revenue growthQuanterix revenue growthCue Biopharma free cash flowQuanterix free cash flow
Cue Biopharma & Quanterix appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.